Hochschulschrift
New approaches to improve prediction of drug-induced liver injury
- Alternative title
-
Neue Ansätze zur verbesserten Vorhersage arzneimittelinduzierter Leberschäden
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Würzburg, Universität Würzburg, Diss., 2012
- Keyword
-
Biomarker ; Leber ; Lebertoxizität
Arzneimittelentwicklung
Arzneimitteldesign
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universitätsbibliothek der Universität Würzburg
- (when)
-
2012
- Creator
-
Adler, Melanie
- Contributor
-
Mally, Angela
- URN
-
urn:nbn:de:bvb:20-opus-69512
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Adler, Melanie
- Mally, Angela
- Universitätsbibliothek der Universität Würzburg
Time of origin
- 2012
Other Objects (12)
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Improved early in vitro prediction of drug-induced liver injury in man: assessment of novel 3D hepatic models
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Improved early in vitro prediction of drug-induced liver injury in man: assessment of novel 3D hepatic models
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Improved early in vitro prediction of drug-induced liver injury in man: assessment of novel 3D hepatic models
Drug induced liver injury : can biomarkers assist RUCAM in causality assessment?